{"id":62873,"date":"2026-03-31T22:03:01","date_gmt":"2026-03-31T20:03:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/"},"modified":"2026-03-31T22:03:01","modified_gmt":"2026-03-31T20:03:01","slug":"mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/","title":{"rendered":"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber"},"content":{"rendered":"
\n

\nDBX portfolio expands with fiber tissue form, processed for addressing complex fusion environments<\/i><\/b><\/p>\n

EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics<\/a>, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis\u00ae<\/sup><\/b><\/a>, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber\u00ae<\/sup><\/b>, the latest addition to the DBX\u00ae<\/sup><\/b> family.<\/p>\n

<\/a>
<\/a><\/p>\n

\nFor decades, DBX has been a trusted name in demineralized bone matrix, earning its reputation through proven performance in operating rooms around the world. DBX Fiber expands the DBX portfolio with a fiber tissue form processed to provide surgeons with superior handling and osteoinductive potential when addressing complex anatomy and challenging fusion environments.<\/p>\n

\n\u201cDBX has long been recognized for its reliable performance and proven processing methods,\u201d said Brad Bailey, Vice President and General Manager of MTF Biologics\u2019 Orthopedic Franchise. \u201cWe\u2019re proud to expand the DBX family and strengthen our partnership with Kolosis by bringing surgeons another option within a tissue portfolio line they know and trust.\u201d<\/p>\n

\nThrough its partnership with MTF Biologics, Kolosis continues to expand access to innovative biologic technologies for surgeons across spine and orthopedic procedures. The addition of DBX Fiber enhances Kolosis\u2019 best-in-class portfolio of surgical biologics, which already includes DBX Mix\u00ae<\/sup> and DBX Putty\u00ae<\/sup>, as well as technologies such as Kore Fiber\u00ae<\/sup>, a 100% cortical bone allograft, and Summit Matrix\u2122<\/sup>, an advanced synthetic bone graft manufactured to support bone regeneration in orthopedic and spinal procedures.<\/p>\n

\n\u201cKolosis continues to strengthen its position as the leading pure-play orthobiologics provider in spine and orthopedics, and the addition of DBX Fiber is another important step in expanding our portfolio,\u201d said Collin Begley, CEO of Kolosis. \u201cThrough our partnership with MTF Biologics, we\u2019re able to expand the DBX family with a fiber format that offers surgeons greater versatility while continuing to deliver the trusted biologics solutions they rely on.\u201d<\/p>\n

\nAbout MTF Biologics<\/b><\/p>\n

\nMTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. In partnership with organ and tissue recovery organizations, MTF Biologics provides exceptional services, resources, and expertise to donors and their families; tissue and organ transplant patients; and clinicians and scientists who advance patient care.<\/p>\n

\nThe International Institute for the Advancement of Medicine (IIAM)<\/a>, a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized screening, coordination, and communications services to organ transplant centers, organ, tissue, and eye procurement organizations, and the hospitals and patients that they serve. Its sister organization, Deutsches Institut f\u00fcr Zell-und Gewebeersatz<\/a> \u2013 DIZG (The German Institute for Cell and Tissue Transplantation) expands its reach to patients across the globe. For more information, please visit www.mtfbiologics.org<\/a>.<\/p>\n

\nAbout Kolosis BIO<\/b><\/p>\n

\nKolosis BIO is a rising biologics pure-play, dedicated to commercializing cutting-edge technologies to multiple verticals in the surgical biologics space. With a proven track record of scaling market-leading technologies, Kolosis is dedicated to driving innovation and pushing the boundaries of science to enhance patient outcomes. With a focus on providing bold technologies and relentless execution, Kolosis has become a leading force in the surgical biologics market. For more information, please visit www.kolosis.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMTF Media Contact:
\n
Aleksa Loch
\n
Email: aleksa.loch@finnpartners.com<\/a><\/p>\n

\nKolosis Media Contact:
\n
Maxwell Hunter, COO
\n
Email: info@kolosis.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DBX portfolio expands with fiber tissue form, processed for addressing complex fusion environments EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis\u00ae, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber\u00ae, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62873","6":"format-standard","7":"category-industry"},"yoast_head":"\nMTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DBX portfolio expands with fiber tissue form, processed for addressing complex fusion environments EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis\u00ae, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber\u00ae, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-31T20:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260331524927\/en\/2762465\/22\/2402295_press_realease-BizWire.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber\",\"datePublished\":\"2026-03-31T20:03:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/\"},\"wordCount\":584,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260331524927\\\/en\\\/2762465\\\/22\\\/2402295_press_realease-BizWire.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/\",\"name\":\"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260331524927\\\/en\\\/2762465\\\/22\\\/2402295_press_realease-BizWire.jpg\",\"datePublished\":\"2026-03-31T20:03:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260331524927\\\/en\\\/2762465\\\/22\\\/2402295_press_realease-BizWire.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260331524927\\\/en\\\/2762465\\\/22\\\/2402295_press_realease-BizWire.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/","og_locale":"en_US","og_type":"article","og_title":"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber - Pharma Trend","og_description":"DBX portfolio expands with fiber tissue form, processed for addressing complex fusion environments EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis\u00ae, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber\u00ae, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-31T20:03:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260331524927\/en\/2762465\/22\/2402295_press_realease-BizWire.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber","datePublished":"2026-03-31T20:03:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/"},"wordCount":584,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260331524927\/en\/2762465\/22\/2402295_press_realease-BizWire.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/","url":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/","name":"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260331524927\/en\/2762465\/22\/2402295_press_realease-BizWire.jpg","datePublished":"2026-03-31T20:03:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260331524927\/en\/2762465\/22\/2402295_press_realease-BizWire.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260331524927\/en\/2762465\/22\/2402295_press_realease-BizWire.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mtf-biologics-and-kolosis-bio-launch-the-latest-addition-to-the-dbx-family-dbx-fiber\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MTF Biologics\u00ae and Kolosis BIO\u00ae Launch the Latest Addition to the DBX Family: DBX\u00ae Fiber"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62873"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62873\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}